Frequency of respiratory virus-associated infection among children and adolescents from a tertiary-care hospital in Mexico City.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 11 2023
Historique:
received: 04 04 2023
accepted: 08 11 2023
medline: 15 11 2023
pubmed: 14 11 2023
entrez: 13 11 2023
Statut: epublish

Résumé

Acute respiratory infections (ARIs) are a major cause of morbidity and mortality among children. The causative pathogens show geographic and seasonal variations. We retrospectively evaluated the frequency and seasonality of respiratory pathogens in children and adolescents (age: 0-19 years) with ARIs treated between January 1, 2021, and March 31, 2022, at a single center in Mexico. Out of 2400 patients, 1,603 were diagnosed with SARS-CoV-2 infection and 797 were diagnosed with other common respiratory pathogens (CRPs). Of the 797 patients, 632 were infected with one CRP and 165 with > 2 CRPs. Deaths occurred only in SARS-CoV-2-infected patients. Rhinovirus/Enterovirus, respiratory syncytial virus B, and parainfluenza virus 3 were the most prevalent in cases with single and multiple infections. CRP showed a high frequency between autumn and winter of 2021, with higher incidence of hospitalization compared to COVID-19. The main comorbidities were immunosuppression, cardiovascular disease (CD), and asthma. The frequency of CRPs showed a downward trend throughout the first half of 2021. CRPs increased in single- and co-infection cases between the fourth and fifth waves of COVID-19, probably due to decreased nonpharmaceutical interventions and changes in diagnostic tests. Age, cyanosis (symptom), and immunosuppression (comorbidity) were found to differentiate between SARS-CoV-2 infection and CRP infection.

Identifiants

pubmed: 37957308
doi: 10.1038/s41598-023-47035-6
pii: 10.1038/s41598-023-47035-6
pmc: PMC10643542
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19763

Informations de copyright

© 2023. The Author(s).

Références

N Engl J Med. 2015 Feb 26;372(9):835-45
pubmed: 25714161
Pathogens. 2022 Oct 13;11(10):
pubmed: 36297238
Sci Rep. 2021 May 24;11(1):10730
pubmed: 34031515
Int J Infect Dis. 2023 Mar;128:132-139
pubmed: 36608787
Front Pediatr. 2021 Sep 28;9:716351
pubmed: 34650939
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3243-8
pubmed: 19204283
EMBO Mol Med. 2022 Apr 7;14(4):e15352
pubmed: 35157360
Virol J. 2012 Apr 10;9:78
pubmed: 22490115
Eur Respir J. 2013 Aug;42(2):461-9
pubmed: 23645407
Clin Microbiol Infect. 2021 Apr;27(4):631.e1-631.e6
pubmed: 32540470
Int J Infect Dis. 2017 Sep;62:32-38
pubmed: 28673837
Front Microbiol. 2022 Jul 05;13:886585
pubmed: 35865920
Infect Dis Now. 2021 Aug;51(5):418-423
pubmed: 33991720
BMC Pediatr. 2022 Mar 31;22(1):169
pubmed: 35361166
Infection. 2020 Dec;48(6):871-877
pubmed: 32725598
J Am Heart Assoc. 2020 Jun 16;9(12):e017224
pubmed: 32441586
Am J Med. 2002 Apr 22;112 Suppl 6A:4S-12S
pubmed: 11955454
Nat Rev Microbiol. 2023 Mar;21(3):195-210
pubmed: 36253478
Am J Med. 2021 Oct;134(10):1247-1251
pubmed: 34242620
Lancet Child Adolesc Health. 2021 Dec;5(12):e44-e45
pubmed: 34695374
Viruses. 2023 Jan 15;15(1):
pubmed: 36680283
Microbiol Spectr. 2022 Aug 31;10(4):e0124822
pubmed: 35766513
Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:25-31
pubmed: 23116789
Paediatr Int Child Health. 2016 May;36(2):84-90
pubmed: 25936959
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Int J Pediatr. 2016;2016:7235482
pubmed: 28018433
Clin Microbiol Infect. 2020 Jul;26(7):947.e1-947.e4
pubmed: 32205296
PLoS One. 2017 Mar 27;12(3):e0174488
pubmed: 28346512
Children (Basel). 2022 Sep 24;9(10):
pubmed: 36291400
EClinicalMedicine. 2023 Jun;60:102000
pubmed: 37197226
Pediatr Infect Dis J. 2022 Apr 1;41(4):e146-e148
pubmed: 35175993
PLoS One. 2017 May 3;12(5):e0176298
pubmed: 28467515
Int J Infect Dis. 2022 May;118:197-202
pubmed: 35257905
PLoS One. 2022 Aug 15;17(8):e0273097
pubmed: 35969583
Emerg Infect Dis. 2023 Sep;29(9):1808-1817
pubmed: 37610149
BMC Infect Dis. 2015 Nov 14;15:515
pubmed: 26567015
Pediatr Obes. 2022 Sep;17(9):e12920
pubmed: 35481672
Annu Rev Virol. 2020 Sep 29;7(1):83-101
pubmed: 32196426
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Pediatr Obes. 2022 Mar;17(3):e12856
pubmed: 34581027
Adv Med Sci. 2011;56(1):56-63
pubmed: 21515486
World J Virol. 2021 Jul 25;10(4):168-181
pubmed: 34367932
Lancet Reg Health Am. 2023 Aug 30;25:100582
pubmed: 37705884
Pediatr Infect Dis J. 2019 Dec;38(12):1199-1203
pubmed: 31738334
Trop Med Infect Dis. 2022 Oct 31;7(11):
pubmed: 36355882
J Allergy Clin Immunol. 2014 May;133(5):1301-7, 1307.e1-3
pubmed: 24698319
Gac Med Mex. 2020;156(4):265-272
pubmed: 32831337
Viruses. 2022 Sep 30;14(10):
pubmed: 36298717
BMC Infect Dis. 2022 Jan 31;22(1):108
pubmed: 35100984
Front Pediatr. 2022 Aug 11;10:935483
pubmed: 36034546
Nat Microbiol. 2022 Jan;7(1):16-17
pubmed: 34972824
Pediatr Infect Dis J. 2013 Mar;32(3):e105-10
pubmed: 23190781
J Infect Public Health. 2023 Sep;16(9):1403-1409
pubmed: 37480671
Exp Ther Med. 2018 Jun;15(6):4805-4809
pubmed: 29805499
Salud Publica Mex. 2013;55 Suppl 2:S307-13
pubmed: 24626709
PLoS One. 2016 May 19;11(5):e0154970
pubmed: 27196667
J Med Microbiol. 2021 Apr;70(4):
pubmed: 33861190
Lancet Reg Health Am. 2022 Apr;8:100184
pubmed: 35079726
Clin Microbiol Infect. 2012 Oct;18(10):946-54
pubmed: 22817528
Clin Chem Lab Med. 2020 Jun 25;58(7):1160-1161
pubmed: 32301747
J Clin Virol. 2017 Sep;94:72-78
pubmed: 28772168
Sci Rep. 2023 Aug 28;13(1):14013
pubmed: 37640709
Influenza Other Respir Viruses. 2015 Nov;9(6):287-292
pubmed: 26289993
Am J Infect Control. 2020 Oct;48(10):1231-1236
pubmed: 32113661
Salud Publica Mex. 2010 Nov-Dec;52(6):528-32
pubmed: 21271012
Am J Transplant. 2020 Dec;20(12):3681-3685
pubmed: 33264506

Auteurs

Brenda Nieto-Rivera (B)

Departamento de Laboratorio Clínico, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Zeus Saldaña-Ahuactzi (Z)

Centro de Investigación en Biotecnología Aplicada, Instituto Politécnico Nacional, Santa Inés Tecuexcomac, Tepetitla de Lardizábal, Tlaxcala, México.

Israel Parra-Ortega (I)

Departamento de Laboratorio Clínico, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Alejandro Flores-Alanis (A)

Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.

Ebzadrel Carbajal-Franco (E)

Departamento de Laboratorio Clínico, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Armando Cruz-Rangel (A)

Laboratorio de Bioquímica de Enfermedades Crónicas, Instituto Nacional de Medicina Genómica, Ciudad de México, México.

Stephania Galaviz-Hernández (S)

Departamento de Laboratorio Clínico, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Benjamín Romero-Navarro (B)

Subdirección de Servicios Auxiliares de Diagnóstico, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Daniela de la Rosa-Zamboni (D)

Subdirección de Atención Integral al Paciente, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Marcela Salazar-García (M)

Laboratorio de Biología del Desarrollo y Teratogénesis Experimental, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Carmen A Contreras (CA)

Facultad de Medicina, Universidad Privada Antenor Orrego, Trujillo, Peru.

Fernando Ortega-Riosvelasco (F)

Departamento de Epidemiología Clínica, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Irma López-Martínez (I)

Dirección de Diagnóstico y Referencia, Instituto de Diagnóstico y Referencia Epidemiológicos, Ciudad de México, México.

Gisela Barrera-Badillo (G)

Laboratorio de Virus Respiratorios, Instituto de Diagnóstico y Referencia Epidemiológicos, Ciudad de México, México.

Hector Diaz-Garcia (H)

Centro de Investigación en Malformaciones Congénitas, Hospital Infantil de México Federico Gómez, Ciudad de México, México.
Escuela Superior de Enfermería y Obstetricia, Instituto Politécnico Nacional, Ciudad de México, México.

Mariana Romo-Castillo (M)

Laboratorio de Investigación en COVID-19, Laboratorio de Investigación en Inmunología y Proteomica, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Sarbelio Moreno-Espinosa (S)

Dirección de Enseñanza, Hospital Infantil de México Federico Gómez, Ciudad de México, México.

Victor M Luna-Pineda (VM)

Laboratorio de Investigación en COVID-19, Laboratorio de Investigación en Inmunología y Proteomica, Hospital Infantil de México Federico Gómez, Ciudad de México, México. luna.pineda@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH